๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Development of novel antiviral therapies for hepatitis C virus

โœ Scribed by Kai Lin


Book ID
107636113
Publisher
SP Wuhan Institute of Virology, CAS
Year
2010
Tongue
English
Weight
526 KB
Volume
25
Category
Article
ISSN
1674-0769

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Clearance kinetics of hepatitis C virus
โœ Francesco Torre; Rosella Giusto; Alessandro Grasso; Renata Brizzolara; Nadia Cam ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 102 KB ๐Ÿ‘ 1 views

## Abstract Interferon alpha (IFN) has been the standard treatment for hepatitis C virus (HCV) infection. Using the kinetic curves of viral clearance, this study compared three treatment regimes based on IFN alone or in combination with Amantadine or Ribavirin to determine the mechanisms of action

Antiviral therapy for hepatitis C
โœ Michelle M. Lipman; Scott J. Cotler ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› Springer ๐ŸŒ English โš– 350 KB
Triphasic decline of hepatitis C virus R
โœ Harel Dahari; Ruy M. Ribeiro; Alan S. Perelson ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 237 KB ๐Ÿ‘ 1 views

When patients chronically infected with hepatitis C virus (HCV) are placed on antiviral therapy with pegylated interferon (IFN)-โฃ or IFN-โฃ plus ribavirin (RBV), HCV RNA generally declines in a biphasic manner. However, a triphasic decline has been reported in a subset of patients. A triphasic declin